Company news

Insmed Incorporated news in 2023

Insmed Incorporated's news releases, calls and decks from 2023, newest first.

View company

Insmed To Present at the Nasdaq 49th Investor Conference

November 28, 2023

Insmed To Present at Two November Conferences

November 7, 2023

Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the Globe

November 1, 2023

Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update

October 25, 2023

Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List

October 25, 2023

Insmed and Google Cloud Collaborate to Transform the Lives of Patients by Harnessing the Power of AI

October 23, 2023

Insmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023

October 11, 2023

Insmed To Present at Chardan's 7th Annual Genetic Medicines Conference

September 25, 2023

Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference

September 5, 2023

Insmed announces positive topline results from Phase 3 ARISE study of ARIKAYCE® (amikacin liposome inhalation suspension) in patients with NTM lung disease caused by MAC

September 4, 2023

Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update

August 2, 2023

Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023

July 19, 2023

Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference

June 6, 2023

Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference

May 21, 2023

Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"

May 7, 2023

Insmed Reports First Quarter 2023 Financial Results and Provides Business Update

May 3, 2023

Insmed to Host Investor and Analyst Event on May 8, 2023

April 23, 2023

Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023

April 19, 2023

Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis

March 30, 2023

Insmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference

March 23, 2023

Insmed To Present at Two March Conferences

February 28, 2023

Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

February 22, 2023

Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023

February 8, 2023

Insmed To Present at the SVB Securities Global Biopharma Conference

February 6, 2023

Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference

January 5, 2023

Insmed To Present at the 41st Annual J.P. Morgan Healthcare Conference

January 2, 2023

Calls in 2023

Decks in 2023